Varex Imaging Corporation (NASDAQ: VREX) Stock Competitors & Peer Comparison
See VREX's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for VREX and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| VREX | $18.47 | +0.05% | 777.6M | 19.44 | $0.95 | N/A |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| ABT | $100.94 | -0.04% | 174.7B | 19.37 | $5.21 | +2.46% |
| MDT | $87.12 | -2.66% | 111.5B | 15.75 | $5.53 | +3.22% |
| SYK | $278.86 | +1.29% | 106.9B | 20.83 | $13.39 | +1.27% |
| BSX | $43.85 | -0.59% | 65.2B | 14.15 | $3.10 | N/A |
| EW | $88.11 | +1.47% | 50.7B | 32.63 | $2.70 | N/A |
| DXCM | $86.64 | -0.05% | 32.7B | 33.98 | $2.55 | N/A |
| GEHC | $66.46 | -0.48% | 30B | 14.57 | $4.56 | +0.21% |
| PHG | $24.77 | -1.35% | 24.2B | 14.15 | $1.75 | +3.94% |
Stock Comparison
Boston Scientific Corporation (NYSE: BSX-PA)
VREX vs BSX-PA Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, VREX's ROE is +0.05%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, VREX is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for VREX.Check BSX-PA's competition here
Abbott Laboratories (NYSE: ABT)
VREX vs ABT Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, ABT has a market cap of 174.7B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while ABT trades at $100.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas ABT's P/E ratio is 19.37. In terms of profitability, VREX's ROE is +0.05%, compared to ABT's ROE of +0.11%. Regarding short-term risk, VREX is less volatile compared to ABT. This indicates lower risk in terms of short-term price fluctuations for VREX.Check ABT's competition here
Medtronic plc (NYSE: MDT)
VREX vs MDT Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, MDT has a market cap of 111.5B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while MDT trades at $87.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas MDT's P/E ratio is 15.75. In terms of profitability, VREX's ROE is +0.05%, compared to MDT's ROE of +0.11%. Regarding short-term risk, VREX is less volatile compared to MDT. This indicates lower risk in terms of short-term price fluctuations for VREX.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
VREX vs SYK Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, SYK has a market cap of 106.9B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while SYK trades at $278.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas SYK's P/E ratio is 20.83. In terms of profitability, VREX's ROE is +0.05%, compared to SYK's ROE of +0.16%. Regarding short-term risk, VREX is less volatile compared to SYK. This indicates lower risk in terms of short-term price fluctuations for VREX.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
VREX vs BSX Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, BSX has a market cap of 65.2B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while BSX trades at $43.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas BSX's P/E ratio is 14.15. In terms of profitability, VREX's ROE is +0.05%, compared to BSX's ROE of +0.15%. Regarding short-term risk, VREX is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for VREX.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
VREX vs EW Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, EW has a market cap of 50.7B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while EW trades at $88.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas EW's P/E ratio is 32.63. In terms of profitability, VREX's ROE is +0.05%, compared to EW's ROE of +0.10%. Regarding short-term risk, VREX is less volatile compared to EW. This indicates lower risk in terms of short-term price fluctuations for VREX.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
VREX vs DXCM Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, DXCM has a market cap of 32.7B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while DXCM trades at $86.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas DXCM's P/E ratio is 33.98. In terms of profitability, VREX's ROE is +0.05%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, VREX is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for VREX.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
VREX vs GEHC Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, GEHC has a market cap of 30B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while GEHC trades at $66.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas GEHC's P/E ratio is 14.57. In terms of profitability, VREX's ROE is +0.05%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, VREX is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for VREX.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
VREX vs PHG Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, PHG has a market cap of 24.2B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while PHG trades at $24.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas PHG's P/E ratio is 14.15. In terms of profitability, VREX's ROE is +0.05%, compared to PHG's ROE of +0.10%. Regarding short-term risk, VREX is less volatile compared to PHG. This indicates lower risk in terms of short-term price fluctuations for VREX.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
VREX vs ZBH Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, ZBH has a market cap of 17.7B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while ZBH trades at $91.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas ZBH's P/E ratio is 10.77. In terms of profitability, VREX's ROE is +0.05%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, VREX is less volatile compared to ZBH. This indicates lower risk in terms of short-term price fluctuations for VREX.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
VREX vs ABMD Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas ABMD's P/E ratio is 65.36. In terms of profitability, VREX's ROE is +0.05%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, VREX is less volatile compared to ABMD. This indicates lower risk in terms of short-term price fluctuations for VREX.Check ABMD's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
VREX vs SWAV Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas SWAV's P/E ratio is 78.76. In terms of profitability, VREX's ROE is +0.05%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, VREX is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for VREX.Check SWAV's competition here
Penumbra, Inc. (NYSE: PEN)
VREX vs PEN Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while PEN trades at $318.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas PEN's P/E ratio is 83.26. In terms of profitability, VREX's ROE is +0.05%, compared to PEN's ROE of +0.11%. Regarding short-term risk, VREX is less volatile compared to PEN. This indicates lower risk in terms of short-term price fluctuations for VREX.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
VREX vs SNN Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, SNN has a market cap of 11.3B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while SNN trades at $26.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas SNN's P/E ratio is 18.19. In terms of profitability, VREX's ROE is +0.05%, compared to SNN's ROE of +0.12%. Regarding short-term risk, VREX is less volatile compared to SNN. This indicates lower risk in terms of short-term price fluctuations for VREX.Check SNN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
VREX vs BIO-B Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, BIO-B has a market cap of 10.5B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while BIO-B trades at $385.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas BIO-B's P/E ratio is -67.89. In terms of profitability, VREX's ROE is +0.05%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, VREX is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for VREX.Check BIO-B's competition here
Align Technology, Inc. (NASDAQ: ALGN)
VREX vs ALGN Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, ALGN has a market cap of 10.3B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while ALGN trades at $144.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas ALGN's P/E ratio is 13.13. In terms of profitability, VREX's ROE is +0.05%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, VREX is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for VREX.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
VREX vs BIO Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, BIO has a market cap of 10.2B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while BIO trades at $379.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas BIO's P/E ratio is 40.90. In terms of profitability, VREX's ROE is +0.05%, compared to BIO's ROE of +0.03%. Regarding short-term risk, VREX is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for VREX.Check BIO's competition here
Globus Medical, Inc. (NYSE: GMED)
VREX vs GMED Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, GMED has a market cap of 10.2B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while GMED trades at $75.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas GMED's P/E ratio is 17.06. In terms of profitability, VREX's ROE is +0.05%, compared to GMED's ROE of +0.12%. Regarding short-term risk, VREX is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for VREX.Check GMED's competition here
Bruker Corporation (NASDAQ: BRKR)
VREX vs BRKR Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, BRKR has a market cap of 9.8B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while BRKR trades at $64.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas BRKR's P/E ratio is 32.42. In terms of profitability, VREX's ROE is +0.05%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, VREX is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for VREX.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
VREX vs BRKRP Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, BRKRP has a market cap of 9.5B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while BRKRP trades at $472.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas BRKRP's P/E ratio is 256.72. In terms of profitability, VREX's ROE is +0.05%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, VREX is less volatile compared to BRKRP. This indicates lower risk in terms of short-term price fluctuations for VREX.Check BRKRP's competition here
Masimo Corporation (NASDAQ: MASI)
VREX vs MASI Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas MASI's P/E ratio is 44.43. In terms of profitability, VREX's ROE is +0.05%, compared to MASI's ROE of +0.09%. Regarding short-term risk, VREX is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for VREX.Check MASI's competition here
Glaukos Corporation (NYSE: GKOS)
VREX vs GKOS Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, GKOS has a market cap of 9.4B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while GKOS trades at $158.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas GKOS's P/E ratio is -184.34. In terms of profitability, VREX's ROE is +0.05%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, VREX is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for VREX.Check GKOS's competition here
Insulet Corp. (NASDAQ: PODD)
VREX vs PODD Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, PODD has a market cap of 9.2B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while PODD trades at $132.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas PODD's P/E ratio is 22.63. In terms of profitability, VREX's ROE is +0.05%, compared to PODD's ROE of +0.27%. Regarding short-term risk, VREX is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for VREX.Check PODD's competition here
Haemonetics Corporation (NYSE: HAE)
VREX vs HAE Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, HAE has a market cap of 4.8B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while HAE trades at $105.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas HAE's P/E ratio is 21.13. In terms of profitability, VREX's ROE is +0.05%, compared to HAE's ROE of +0.11%. Regarding short-term risk, VREX is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for VREX.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
VREX vs NARI Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas NARI's P/E ratio is -59.24. In terms of profitability, VREX's ROE is +0.05%, compared to NARI's ROE of -0.00%. Regarding short-term risk, VREX is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for VREX.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
VREX vs ITGR Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while ITGR trades at $126.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas ITGR's P/E ratio is 19.90. In terms of profitability, VREX's ROE is +0.05%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, VREX is less volatile compared to ITGR. This indicates lower risk in terms of short-term price fluctuations for VREX.Check ITGR's competition here
LivaNova PLC (NASDAQ: LIVN)
VREX vs LIVN Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, LIVN has a market cap of 4.2B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while LIVN trades at $76.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas LIVN's P/E ratio is 18.29. In terms of profitability, VREX's ROE is +0.05%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, VREX is less volatile compared to LIVN. This indicates lower risk in terms of short-term price fluctuations for VREX.Check LIVN's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
VREX vs IRTC Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, IRTC has a market cap of 3.8B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while IRTC trades at $114.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas IRTC's P/E ratio is -265.63. In terms of profitability, VREX's ROE is +0.05%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, VREX is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for VREX.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
VREX vs AXNX Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas AXNX's P/E ratio is -709.80. In terms of profitability, VREX's ROE is +0.05%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, VREX is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for VREX.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
VREX vs TMDX Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, TMDX has a market cap of 2.9B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while TMDX trades at $84.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas TMDX's P/E ratio is 42.68. In terms of profitability, VREX's ROE is +0.05%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, VREX is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for VREX.Check TMDX's competition here
Neogen Corporation (NASDAQ: NEOG)
VREX vs NEOG Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, NEOG has a market cap of 2.8B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while NEOG trades at $12.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas NEOG's P/E ratio is 45.46. In terms of profitability, VREX's ROE is +0.05%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, VREX is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for VREX.Check NEOG's competition here
Butterfly Network, Inc. (NYSE: BFLY)
VREX vs BFLY Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, BFLY has a market cap of 2.4B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while BFLY trades at $9.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas BFLY's P/E ratio is -37.90. In terms of profitability, VREX's ROE is +0.05%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, VREX is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for VREX.Check BFLY's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
VREX vs UFPT Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while UFPT trades at $296.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas UFPT's P/E ratio is 30.33. In terms of profitability, VREX's ROE is +0.05%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, VREX is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for VREX.Check UFPT's competition here
AxoGen, Inc. (NASDAQ: AXGN)
VREX vs AXGN Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, AXGN has a market cap of 2.3B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while AXGN trades at $42.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas AXGN's P/E ratio is 111.68. In terms of profitability, VREX's ROE is +0.05%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, VREX is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for VREX.Check AXGN's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
VREX vs INSP Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, INSP has a market cap of 2.1B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while INSP trades at $73.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas INSP's P/E ratio is 32.26. In terms of profitability, VREX's ROE is +0.05%, compared to INSP's ROE of +0.18%. Regarding short-term risk, VREX is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for VREX.Check INSP's competition here
NuVasive, Inc. (NASDAQ: NUVA)
VREX vs NUVA Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas NUVA's P/E ratio is 75.00. In terms of profitability, VREX's ROE is +0.05%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, VREX is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for VREX.Check NUVA's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
VREX vs ESTA Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, ESTA has a market cap of 1.9B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while ESTA trades at $63.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas ESTA's P/E ratio is -50.56. In terms of profitability, VREX's ROE is +0.05%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, VREX is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for VREX.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
VREX vs NVCR Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, NVCR has a market cap of 1.9B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while NVCR trades at $15.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas NVCR's P/E ratio is -12.30. In terms of profitability, VREX's ROE is +0.05%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, VREX is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for VREX.Check NVCR's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
VREX vs ATEC Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, ATEC has a market cap of 1.6B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while ATEC trades at $10.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas ATEC's P/E ratio is -172.83. In terms of profitability, VREX's ROE is +0.05%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, VREX is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for VREX.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
VREX vs CNMD Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while CNMD trades at $46.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas CNMD's P/E ratio is 10.26. In terms of profitability, VREX's ROE is +0.05%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, VREX is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for VREX.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
VREX vs HSKA Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas HSKA's P/E ratio is -62.49. In terms of profitability, VREX's ROE is +0.05%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, VREX is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for VREX.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
VREX vs IART Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while IART trades at $16.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas IART's P/E ratio is 7.05. In terms of profitability, VREX's ROE is +0.05%, compared to IART's ROE of -0.01%. Regarding short-term risk, VREX is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for VREX.Check IART's competition here
Avanos Medical, Inc. (NYSE: AVNS)
VREX vs AVNS Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas AVNS's P/E ratio is 27.77. In terms of profitability, VREX's ROE is +0.05%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, VREX is less volatile compared to AVNS. This indicates lower risk in terms of short-term price fluctuations for VREX.Check AVNS's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
VREX vs TNDM Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, TNDM has a market cap of 1.1B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while TNDM trades at $16.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas TNDM's P/E ratio is -17.82. In terms of profitability, VREX's ROE is +0.05%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, VREX is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for VREX.Check TNDM's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
VREX vs SILK Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas SILK's P/E ratio is -18.96. In terms of profitability, VREX's ROE is +0.05%, compared to SILK's ROE of -0.35%. Regarding short-term risk, VREX is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for VREX.Check SILK's competition here
Artivion, Inc. (NYSE: AORT)
VREX vs AORT Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while AORT trades at $22.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas AORT's P/E ratio is 38.07. In terms of profitability, VREX's ROE is +0.05%, compared to AORT's ROE of -0.01%. Regarding short-term risk, VREX is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for VREX.Check AORT's competition here
IRadimed Corporation (NASDAQ: IRMD)
VREX vs IRMD Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while IRMD trades at $86.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas IRMD's P/E ratio is 43.45. In terms of profitability, VREX's ROE is +0.05%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, VREX is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for VREX.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
VREX vs FNA Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas FNA's P/E ratio is -19.83. In terms of profitability, VREX's ROE is +0.05%, compared to FNA's ROE of -0.35%. Regarding short-term risk, VREX is less volatile compared to FNA. This indicates lower risk in terms of short-term price fluctuations for VREX.Check FNA's competition here
Enovis Corporation (NYSE: ENOV)
VREX vs ENOV Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, ENOV has a market cap of 1.1B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while ENOV trades at $18.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas ENOV's P/E ratio is 5.29. In terms of profitability, VREX's ROE is +0.05%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, VREX is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for VREX.Check ENOV's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
VREX vs PRCT Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, PRCT has a market cap of 1B. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while PRCT trades at $18.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas PRCT's P/E ratio is -9.39. In terms of profitability, VREX's ROE is +0.05%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, VREX is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for VREX.Check PRCT's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
VREX vs LMRI Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, LMRI has a market cap of 985.8M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while LMRI trades at $10.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas LMRI's P/E ratio is -19.96. In terms of profitability, VREX's ROE is +0.05%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, VREX is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for VREX.Check LMRI's competition here
Bioventus Inc. (NASDAQ: BVS)
VREX vs BVS Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, BVS has a market cap of 948.5M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while BVS trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas BVS's P/E ratio is 18.42. In terms of profitability, VREX's ROE is +0.05%, compared to BVS's ROE of +0.28%. Regarding short-term risk, VREX is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for VREX.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
VREX vs CBLL Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, CBLL has a market cap of 943.3M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while CBLL trades at $24.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas CBLL's P/E ratio is -14.12. In terms of profitability, VREX's ROE is +0.05%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, VREX is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for VREX.Check CBLL's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
VREX vs BBNX Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, BBNX has a market cap of 873.2M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while BBNX trades at $19.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas BBNX's P/E ratio is -11.76. In terms of profitability, VREX's ROE is +0.05%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, VREX is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for VREX.Check BBNX's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
VREX vs SIBN Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, SIBN has a market cap of 849.3M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while SIBN trades at $19.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas SIBN's P/E ratio is -56.32. In terms of profitability, VREX's ROE is +0.05%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, VREX is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for VREX.Check SIBN's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
VREX vs CSII Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas CSII's P/E ratio is -20.83. In terms of profitability, VREX's ROE is +0.05%, compared to CSII's ROE of -0.14%. Regarding short-term risk, VREX is less volatile compared to CSII. This indicates lower risk in terms of short-term price fluctuations for VREX.Check CSII's competition here
InMode Ltd. (NASDAQ: INMD)
VREX vs INMD Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, INMD has a market cap of 817.4M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while INMD trades at $14.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas INMD's P/E ratio is 9.88. In terms of profitability, VREX's ROE is +0.05%, compared to INMD's ROE of +0.12%. Regarding short-term risk, VREX is less volatile compared to INMD. This indicates lower risk in terms of short-term price fluctuations for VREX.Check INMD's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
VREX vs AHCO Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, AHCO has a market cap of 771.4M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while AHCO trades at $5.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas AHCO's P/E ratio is 11.57. In terms of profitability, VREX's ROE is +0.05%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, VREX is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for VREX.Check AHCO's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
VREX vs CTKB Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, CTKB has a market cap of 743.9M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while CTKB trades at $5.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas CTKB's P/E ratio is -30.51. In terms of profitability, VREX's ROE is +0.05%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, VREX is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for VREX.Check CTKB's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
VREX vs AVR Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, AVR has a market cap of 738M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while AVR trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas AVR's P/E ratio is -3.91. In terms of profitability, VREX's ROE is +0.05%, compared to AVR's ROE of -0.78%. Regarding short-term risk, VREX is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for VREX.Check AVR's competition here
Surmodics, Inc. (NASDAQ: SRDX)
VREX vs SRDX Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas SRDX's P/E ratio is -34.66. In terms of profitability, VREX's ROE is +0.05%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, VREX is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for VREX.Check SRDX's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
VREX vs KIDS Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, KIDS has a market cap of 584.6M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while KIDS trades at $22.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas KIDS's P/E ratio is -19.29. In terms of profitability, VREX's ROE is +0.05%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, VREX is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for VREX.Check KIDS's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
VREX vs APEN Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas APEN's P/E ratio is -9.43. In terms of profitability, VREX's ROE is +0.05%, compared to APEN's ROE of -0.85%. Regarding short-term risk, VREX is less volatile compared to APEN. This indicates lower risk in terms of short-term price fluctuations for VREX.Check APEN's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
VREX vs SSII Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, SSII has a market cap of 578.4M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while SSII trades at $2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas SSII's P/E ratio is -48.17. In terms of profitability, VREX's ROE is +0.05%, compared to SSII's ROE of -0.27%. Regarding short-term risk, VREX is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for VREX.Check SSII's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
VREX vs PACB Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, PACB has a market cap of 568.4M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while PACB trades at $1.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas PACB's P/E ratio is -4.46. In terms of profitability, VREX's ROE is +0.05%, compared to PACB's ROE of -49.62%. Regarding short-term risk, VREX is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for VREX.Check PACB's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
VREX vs DCTH Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, DCTH has a market cap of 547.2M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while DCTH trades at $15.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas DCTH's P/E ratio is 1585.00. In terms of profitability, VREX's ROE is +0.05%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, VREX is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for VREX.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
VREX vs ZIMV Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, VREX's ROE is +0.05%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, VREX is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for VREX.Check ZIMV's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
VREX vs SGHT Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, SGHT has a market cap of 508.7M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while SGHT trades at $9.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas SGHT's P/E ratio is -16.70. In terms of profitability, VREX's ROE is +0.05%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, VREX is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for VREX.Check SGHT's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
VREX vs TCMD Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, TCMD has a market cap of 508.2M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while TCMD trades at $22.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas TCMD's P/E ratio is 20.86. In terms of profitability, VREX's ROE is +0.05%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, VREX is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for VREX.Check TCMD's competition here
Cerus Corporation (NASDAQ: CERS)
VREX vs CERS Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, CERS has a market cap of 497.8M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while CERS trades at $2.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas CERS's P/E ratio is -82.06. In terms of profitability, VREX's ROE is +0.05%, compared to CERS's ROE of -0.10%. Regarding short-term risk, VREX is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for VREX.Check CERS's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
VREX vs NPCE Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, NPCE has a market cap of 475.3M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while NPCE trades at $13.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas NPCE's P/E ratio is -24.46. In terms of profitability, VREX's ROE is +0.05%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, VREX is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for VREX.Check NPCE's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
VREX vs SENS Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, SENS has a market cap of 420M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while SENS trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas SENS's P/E ratio is -4.51. In terms of profitability, VREX's ROE is +0.05%, compared to SENS's ROE of -1.66%. Regarding short-term risk, VREX is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for VREX.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
VREX vs OFIX Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, OFIX has a market cap of 394.1M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while OFIX trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas OFIX's P/E ratio is -6.35. In terms of profitability, VREX's ROE is +0.05%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, VREX is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for VREX.Check OFIX's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
VREX vs CLPT Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, CLPT has a market cap of 353M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while CLPT trades at $11.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas CLPT's P/E ratio is -9.97. In terms of profitability, VREX's ROE is +0.05%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, VREX is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for VREX.Check CLPT's competition here
CapsoVision, Inc. (NASDAQ: CV)
VREX vs CV Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, CV has a market cap of 334.3M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while CV trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas CV's P/E ratio is -10.62. In terms of profitability, VREX's ROE is +0.05%, compared to CV's ROE of -1.78%. Regarding short-term risk, VREX is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for VREX.Check CV's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
VREX vs SMLR Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas SMLR's P/E ratio is 3.92. In terms of profitability, VREX's ROE is +0.05%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, VREX is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for VREX.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
VREX vs TMCI Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, TMCI has a market cap of 299.7M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while TMCI trades at $4.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas TMCI's P/E ratio is -4.91. In terms of profitability, VREX's ROE is +0.05%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, VREX is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for VREX.Check TMCI's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
VREX vs CATX Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, CATX has a market cap of 298.8M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while CATX trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas CATX's P/E ratio is -1.97. In terms of profitability, VREX's ROE is +0.05%, compared to CATX's ROE of -0.42%. Regarding short-term risk, VREX is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for VREX.Check CATX's competition here
Avita Medical Inc. (NASDAQ: RCEL)
VREX vs RCEL Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, RCEL has a market cap of 297.1M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while RCEL trades at $11.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas RCEL's P/E ratio is -8.31. In terms of profitability, VREX's ROE is +0.05%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, VREX is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for VREX.Check RCEL's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
VREX vs INFU Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, INFU has a market cap of 263M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while INFU trades at $13.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas INFU's P/E ratio is 31.78. In terms of profitability, VREX's ROE is +0.05%, compared to INFU's ROE of +0.15%. Regarding short-term risk, VREX is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for VREX.Check INFU's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
VREX vs TLSI Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, TLSI has a market cap of 261.7M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while TLSI trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas TLSI's P/E ratio is -2.53. In terms of profitability, VREX's ROE is +0.05%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, VREX is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for VREX.Check TLSI's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
VREX vs MGRM Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas MGRM's P/E ratio is -12.00. In terms of profitability, VREX's ROE is +0.05%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, VREX is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for VREX.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
VREX vs ELMD Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, ELMD has a market cap of 232.9M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while ELMD trades at $28.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas ELMD's P/E ratio is 21.47. In terms of profitability, VREX's ROE is +0.05%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, VREX is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for VREX.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
VREX vs NVRO Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas NVRO's P/E ratio is -1.91. In terms of profitability, VREX's ROE is +0.05%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, VREX is less volatile compared to NVRO. This indicates lower risk in terms of short-term price fluctuations for VREX.Check NVRO's competition here
Profound Medical Corp. (NASDAQ: PROF)
VREX vs PROF Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, PROF has a market cap of 207.9M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while PROF trades at $5.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas PROF's P/E ratio is -5.84. In terms of profitability, VREX's ROE is +0.05%, compared to PROF's ROE of -0.56%. Regarding short-term risk, VREX is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for VREX.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
VREX vs RXST Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, RXST has a market cap of 197.5M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while RXST trades at $4.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas RXST's P/E ratio is -4.22. In terms of profitability, VREX's ROE is +0.05%, compared to RXST's ROE of -0.17%. Regarding short-term risk, VREX is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for VREX.Check RXST's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
VREX vs BSGM Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas BSGM's P/E ratio is -5.81. In terms of profitability, VREX's ROE is +0.05%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, VREX is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for VREX.Check BSGM's competition here
Quantum-Si incorporated (NASDAQ: QSI)
VREX vs QSI Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, QSI has a market cap of 189.5M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while QSI trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas QSI's P/E ratio is -2.08. In terms of profitability, VREX's ROE is +0.05%, compared to QSI's ROE of -0.47%. Regarding short-term risk, VREX is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for VREX.Check QSI's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
VREX vs MDGS Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas MDGS's P/E ratio is -0.27. In terms of profitability, VREX's ROE is +0.05%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, VREX is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for VREX.Check MDGS's competition here
Quanterix Corporation (NASDAQ: QTRX)
VREX vs QTRX Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, QTRX has a market cap of 172.9M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while QTRX trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas QTRX's P/E ratio is -1.44. In terms of profitability, VREX's ROE is +0.05%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, VREX is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for VREX.Check QTRX's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
VREX vs FOCL Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, FOCL has a market cap of 170.2M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while FOCL trades at $4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas FOCL's P/E ratio is -4.39. In terms of profitability, VREX's ROE is +0.05%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, VREX is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for VREX.Check FOCL's competition here
Neuronetics, Inc. (NASDAQ: STIM)
VREX vs STIM Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, STIM has a market cap of 164.2M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while STIM trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas STIM's P/E ratio is -5.36. In terms of profitability, VREX's ROE is +0.05%, compared to STIM's ROE of -1.51%. Regarding short-term risk, VREX is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for VREX.Check STIM's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
VREX vs QIPT Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas QIPT's P/E ratio is -15.87. In terms of profitability, VREX's ROE is +0.05%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, VREX is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for VREX.Check QIPT's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
VREX vs LUCD Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, LUCD has a market cap of 154.3M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while LUCD trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas LUCD's P/E ratio is -2.19. In terms of profitability, VREX's ROE is +0.05%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, VREX is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for VREX.Check LUCD's competition here
Inogen, Inc. (NASDAQ: INGN)
VREX vs INGN Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, INGN has a market cap of 145.4M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while INGN trades at $5.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas INGN's P/E ratio is -5.90. In terms of profitability, VREX's ROE is +0.05%, compared to INGN's ROE of -0.13%. Regarding short-term risk, VREX is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for VREX.Check INGN's competition here
iCAD, Inc. (NASDAQ: ICAD)
VREX vs ICAD Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas ICAD's P/E ratio is -20.37. In terms of profitability, VREX's ROE is +0.05%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, VREX is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for VREX.Check ICAD's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
VREX vs HJLI Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas HJLI's P/E ratio is N/A. In terms of profitability, VREX's ROE is +0.05%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, VREX is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for VREX.Check HJLI's competition here
electroCore, Inc. (NASDAQ: ECOR)
VREX vs ECOR Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, ECOR has a market cap of 98.1M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while ECOR trades at $10.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas ECOR's P/E ratio is -6.48. In terms of profitability, VREX's ROE is +0.05%, compared to ECOR's ROE of +5.25%. Regarding short-term risk, VREX is less volatile compared to ECOR. This indicates lower risk in terms of short-term price fluctuations for VREX.Check ECOR's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
VREX vs ASXC Comparison September 2026
Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VREX stands at 777.6M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, VREX is priced at $18.47 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VREX currently has a P/E ratio of 19.44, whereas ASXC's P/E ratio is -1.12. In terms of profitability, VREX's ROE is +0.05%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, VREX is less volatile compared to ASXC. This indicates lower risk in terms of short-term price fluctuations for VREX.Check ASXC's competition here